OLAPLEX Acquires Biotech Company Purvala
OLAPLEX (NASDAQ: OLPX), the haircare brand known for its bond-building technology, has announced its first-ever acquisition of Purvala Bioscience, a Boston-based biotech company. Founded in 2020, Purvala specializes in developing bioinspired technologies for health and beauty applications, led by MIT Professor Dr. Bradley Olsen and colleagues.
The strategic acquisition aims to enhance OLAPLEX's product innovation capabilities, combining Purvala's expertise in high-performing molecular development with OLAPLEX's existing patent-protected bond-building technology, Bis-amino. CEO Amanda Baldwin emphasized the company's commitment to scientific breakthroughs and delivering innovative products to their stylist community and customers.
OLAPLEX (NASDAQ: OLPX), il marchio di haircare noto per la sua tecnologia che ricostruisce i legami, ha annunciato la sua prima acquisizione: Purvala Bioscience, una biotech con sede a Boston. Fondata nel 2020, Purvala 猫 specializzata nello sviluppo di tecnologie bioispirate per applicazioni nel settore health & beauty, guidata dal professor del MIT Dr. Bradley Olsen e dal suo team.
L'operazione strategica punta a potenziare le capacit脿 di innovazione prodotto di OLAPLEX, unendo l'esperienza di Purvala nello sviluppo di molecole ad alte prestazioni alla tecnologia brevettata di OLAPLEX per la ricostruzione dei legami, il Bis-amino. La CEO Amanda Baldwin ha sottolineato l'impegno dell'azienda verso progressi scientifici e il lancio di prodotti innovativi per la comunit脿 di stylist e i clienti.
OLAPLEX (NASDAQ: OLPX), la marca de cuidado capilar conocida por su tecnolog铆a de reconstrucci贸n de enlaces, ha anunciado su primera adquisici贸n: Purvala Bioscience, una empresa biotecnol贸gica con sede en Boston. Fundada en 2020, Purvala se especializa en desarrollar tecnolog铆as bioinspiradas para aplicaciones de salud y belleza, liderada por el profesor del MIT Dr. Bradley Olsen y su equipo.
La adquisici贸n estrat茅gica busca reforzar la capacidad de innovaci贸n de productos de OLAPLEX, combinando la pericia de Purvala en el desarrollo de mol茅culas de alto rendimiento con la tecnolog铆a patentada de OLAPLEX para la reconstrucci贸n de enlaces, Bis-amino. La CEO Amanda Baldwin enfatiz贸 el compromiso de la compa帽铆a con los avances cient铆ficos y la entrega de productos innovadores a la comunidad de estilistas y a los clientes.
OLAPLEX (NASDAQ: OLPX)電� 瓴绊暕 氤奠洂(氤鸽摐 牍岆敥) 旮办垹搿� 鞙犽獏頃� 項れ柎旒�鞏� 敫岆灉霌滊, 氤挫姢韯� 靻岇灛 氚旍澊鞓ろ厡韥� 旮办梾 Purvala Bioscience毳� 觳橃潓鞙茧 鞚胳垬頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 2020雲勳棎 靹る霅� Purvala電� MIT 甑愳垬 Dr. Bradley Olsen瓿� 霃欕霌れ澊 鞚措亴氅�, 項姢路敕绊嫲 鞚戩毄鞚� 鞙勴暅 氚旍澊鞓� 鞓侁皭 旮办垹 臧滊皽鞚� 鞝勲鞙茧 頃╇媹雼�.
鞚措矆 鞝勲灥鞝� 鞚胳垬電� Purvala鞚� 瓿犾劚電� 攵勳瀽 臧滊皽 鞐焿瓿� OLAPLEX鞚� 韸鬼棃 氤挫湢 瓴绊暕 氤奠洂 旮办垹鞚� Bis-amino毳� 瓴绊暕頃� 鞝滍拡 順侅嫚 電ル牓鞚� 臧曧檾頃橂姅 瓴冹澊 氇╈爜鞛呺媹雼�. CEO Amanda Baldwin鞚� 瓿柬暀鞝� 順侅嫚瓿� 鞀ろ儉鞚茧Μ鞀ろ姼 旎る雼堩嫲 氚� 瓿犼皾鞐愱矊 順侅嫚鞝侅澑 鞝滍拡鞚� 鞝滉车頃橁矤雼る姅 鞚橃毳� 臧曥“頄堨姷雼堧嫟.
OLAPLEX (NASDAQ: OLPX), la marque de soins capillaires r茅put茅e pour sa technologie de reconstruction des liaisons, a annonc茅 sa premi猫re acquisition : Purvala Bioscience, une biotech bas茅e 脿 Boston. Fond茅e en 2020, Purvala se sp茅cialise dans le d茅veloppement de technologies bioinspir茅es pour des applications sant茅 et beaut茅, dirig茅e par le professeur du MIT Dr Bradley Olsen et ses coll猫gues.
Cette acquisition strat茅gique vise 脿 renforcer les capacit茅s d'innovation produit d'OLAPLEX, en alliant l'expertise de Purvala dans le d茅veloppement de mol茅cules performantes 脿 la technologie prot茅g茅e par brevet d'OLAPLEX pour la reconstruction des liaisons, le Bis-amino. La CEO Amanda Baldwin a insist茅 sur l'engagement de l'entreprise envers les avanc茅es scientifiques et la mise 脿 disposition de produits innovants pour la communaut茅 de stylistes et les clients.
OLAPLEX (NASDAQ: OLPX), die Haarpflege-Marke, die f眉r ihre bindungsaufbauende Technologie bekannt ist, hat ihre erste 脺bernahme angek眉ndigt: Purvala Bioscience, ein Biotech-Unternehmen mit Sitz in Boston. Purvala wurde 2020 gegr眉ndet und spezialisiert sich auf die Entwicklung bioinspirierter Technologien f眉r Gesundheits- und Sch枚nheitsanwendungen, geleitet von MIT-Professor Dr. Bradley Olsen und seinem Team.
Die strategische 脺bernahme zielt darauf ab, OLAPLEXs Innovationskraft bei Produkten zu st盲rken, indem Purvalas Expertise in der Entwicklung leistungsf盲higer Molek眉le mit OLAPLEXs patentierter bindungsaufbauender Technologie, Bis-amino, kombiniert wird. CEO Amanda Baldwin betonte das Bekenntnis des Unternehmens zu wissenschaftlichen Durchbr眉chen und zur Einf眉hrung innovativer Produkte f眉r Stylisten und Kundinnen und Kunden.
- First strategic acquisition in company's 10-year history shows commitment to growth
- Access to Purvala's advanced biotech expertise and molecular development capabilities
- Integration with MIT-affiliated research leadership through Dr. Bradley Olsen
- Potential for next-generation product innovation in haircare science
- No disclosed financial terms or acquisition cost
- Integration risks with first-time acquisition
- Potential R&D timeline uncertainties for new product development
Ten years after launch, OLAPLEX鈥檚 first acquisition demonstrates its commitment to product innovation
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare.
Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules inspired by naturally occurring biological structures. In addition to his leadership role at Purvala, Dr. Olsen also serves as a Professor of Chemical Engineering at MIT.
鈥淪ince the very beginning, OLAPLEX was founded on the concept of innovation with groundbreaking bond technology that empowered stylists and their clients to achieve transformative results,鈥� said OLAPLEX CEO Amanda Baldwin. 鈥淎nd scientific breakthroughs are what continues to inspire us as we remain committed to delivering the best possible products for our stylist community and our customers. What we鈥檝e accomplished to-date has already left such a meaningful impact on our industry, and we believe that with Purvala we have the potential to create the next generation of disruptive science-backed product innovation alongside our patent-protected bond-building technology, Bis-amino."
For more information, visit .
About OLAPLEX
OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology鈩�, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX鈥檚 award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
Forward-Looking Statements
This press release contains forward-looking statements with respect to, among other things, Olaplex's plans for the development of Purvala's technologies; and the potential to create next generation, disruptive science-backed products. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors on the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Factors that could cause actual results to differ materially include: risks and uncertainties related to the development of the Purvala technologies, including the ability to integrate the technologies into next generation Olaplex products; the risk that we may not be able to realize the expected benefits of the acquisition of Purvala; risks related to the ability to further grow and enhance our product offerings for our stylist community and our customers; and other factors described in our filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 4, 2025, Quarterly Reports on Form 10-Q for the period ended March 31, 2025 filed with the SEC on May 8, 2025 and the period ended June 30, 2025 filed with the SEC on August 7, 2025, and comparable disclosure in our subsequent filings with the SEC. We will make information available in our annual and quarterly reports and other filings with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.
Contacts:
Investors:
Michael Oriolo
Vice President, Investor Relations
尘颈肠丑补别濒.辞谤颈辞濒辞蔼辞濒补辫濒别虫.肠辞尘听
Financial Media:
Lisa Bobroff
Vice President, Global Communications & Consumer Engagement
濒颈蝉补.产辞产谤辞蹿蹿蔼辞濒补辫濒别虫.肠辞尘听
FAQ
What company did OLAPLEX (NASDAQ: OLPX) acquire in August 2025?
Who are the founders of Purvala Bioscience?
What is the strategic importance of OLAPLEX's Purvala acquisition?
When was OLAPLEX's last acquisition before Purvala?
What is OLAPLEX's main technology platform?
